Liquidia LQDA
NASDAQ LQDA
$68.50 +0.82 (+1.20%)
As of: Sep 9, 2026 · 1:03 PM EDT

Liquidia (LQDA) Cost of Revenue (2020 - 2026)

Liquidia (LQDA) posted Cost of Revenue of $10.8 million for Q2 2026, down 2.89% on a QoQ basis from $11.1 million in Q1 2026, and up 732.74% year-over-year from $1.3 million in Q2 2025.

Analysis

Liquidia (LQDA) Cost of Revenue (2020 - 2026) Analysis & Trends

Liquidia has reported Cost of Revenue for 7 years, with the latest figure at $10.8 million in Q2 2026.

  • On a quarterly basis, Cost of Revenue rose 732.74% year-over-year to $10.8 million in Q2 2026; TTM through Jun 2026 was $29.3 million, a 411.0% increase from a year earlier, with the FY2025 full-year figure at $8.8 million, up 50.09% from the prior year.
  • Cost of Revenue was $10.8 million for Q2 2026 at Liquidia, down from $11.1 million in the prior quarter.
  • The five-year high for Cost of Revenue was $11.1 million in Q1 2026, with the low at $570000.0 in Q3 2023.
  • Average Cost of Revenue over 5 years is $2.4 million, with a median of $1.3 million recorded in 2024.
  • The sharpest annual moves came in 2023 and 2026: Cost of Revenue fell 22.97% in 2023, then jumped 732.74% in 2026.
  • Over 5 years, Cost of Revenue stood at $694000.0 in 2022, then jumped by 43.08% to $993000.0 in 2023, then surged by 36.35% to $1.4 million in 2024, then jumped by 279.39% to $5.1 million in 2025, then surged by 109.44% to $10.8 million in 2026.
  • The last three Cost of Revenue figures came in at $10.8 million (Q2 2026), $11.1 million (Q1 2026), and $5.1 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Johnson & Johnson 643.50 Bn 622.74 Bn 17.26 Bn 8.05 Bn
2 AbbVie 440.29 Bn 433.72 Bn 12.70 Bn 4.29 Bn
3 Merck 364.93 Bn 357.79 Bn 12.21 Bn 4.40 Bn
4 Novartis Ag 266.65 Bn 258.96 Bn 11.24 Bn 3.71 Bn
5 Pfizer 158.92 Bn 147.22 Bn 10.94 Bn 4.09 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 3.51 Bn
7 Revolution Medicines 44.32 Bn 44.32 Bn - -
8 Incyte 25.32 Bn 20.78 Bn 1.57 Bn 104.96 Mn
9 United Therapeutics 21.42 Bn 18.75 Bn 683.80 Mn 99.50 Mn
10 Liquidia 6.09 Bn 5.80 Bn 160.92 Mn 10.76 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.76 Mn
Mar 31, 2026 11.08 Mn
Dec 31, 2025 5.14 Mn
Sep 30, 2025 2.30 Mn
Jun 30, 2025 1.29 Mn
Mar 31, 2025 1.52 Mn
Dec 31, 2024 1.35 Mn
Sep 30, 2024 1.57 Mn
Jun 30, 2024 1.49 Mn
Mar 31, 2024 1.47 Mn
Dec 31, 2023 993,000.00
Sep 30, 2023 570,000.00
Jun 30, 2023 671,000.00
Mar 31, 2023 654,000.00
Dec 31, 2022 694,000.00
Sep 30, 2022 740,000.00
Jun 30, 2022 731,000.00
Mar 31, 2022 694,000.00
Dec 31, 2021 726,000.00
Sep 30, 2021 890,000.00